Stay updated with breaking news from Visiox Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to...
/PRNewswire/ -- Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to...
SPARC focuses on discovery and research of novel drugs prioritised in three therapeutic areas i.e. oncology, neurology and immunology. According to the company, during FY22, SPARC raised $148 million to complete the ongoing clinical studies.
/PRNewswire/ -- Visiox Pharma, LLC, a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!